These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1606279)

  • 1. Therapeutic problems in the management of elderly patients with tuberculosis.
    Woo J; Chan HS
    Adverse Drug React Toxicol Rev; 1992; 11(1):13-8. PubMed ID: 1606279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters.
    Woo J; Chan C; Chan R; Cheung W; Or K; Chan K
    J Med; 1995; 26(5-6):279-94. PubMed ID: 8721904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin.
    Chan CH; Or KK; Cheung W; Woo J
    J Med; 1995; 26(1-2):43-52. PubMed ID: 7561530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].
    Aouam K; Chaabane A; Loussaïef C; Ben Romdhane F; Boughattas NA; Chakroun M
    Med Mal Infect; 2007 May; 37(5):253-61. PubMed ID: 17336011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin and pyrazinamide.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):551-6. PubMed ID: 1956210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite.
    Walubo A; Chan K; Woo J; Chan HS; Wong CL
    Methods Find Exp Clin Pharmacol; 1991 Oct; 13(8):545-50. PubMed ID: 1956209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinico-laboratory diagnosis of adverse reactions in children to antitubercular drugs in different combinations].
    Kazakov KS; Zakharova RI; Absadykova FT
    Probl Tuberk; 1990; (9):40-2. PubMed ID: 2274509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of antituberculous drug resistance among Mycobacterium tuberculosis isolates recovered at the American University of Beirut Medical Center: 1996-1998 vs 1994-1995.
    Araj GF; Itani LY; Kanj NA; Jamaleddine GW
    J Med Liban; 2000; 48(1):18-22. PubMed ID: 10881438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of pulmonary tuberculosis in the elderly.
    Das SK; Mukherjee RS; Ghosh IN; Halder AK; Saha SK
    J Indian Med Assoc; 2007 Aug; 105(8):432, 436, 438-9. PubMed ID: 18236905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects in children receiving short-term chemotherapy for intrathoracic tuberculosis].
    Iukhimenko NV
    Probl Tuberk; 2002; (2):24-7. PubMed ID: 11899799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic basis for altered drug action in the elderly.
    Roberts J; Tumer N
    Clin Geriatr Med; 1988 Feb; 4(1):127-49. PubMed ID: 3278786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Desensitization therapy for antituberculous drugs].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Sep; 75(9):521-6. PubMed ID: 11068368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tuberculosis.
    Lordi GM; Reichman LB
    Am Fam Physician; 1991 Jul; 44(1):219-24. PubMed ID: 2058533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.
    Sharma A; Sharma S; Khuller GK
    J Antimicrob Chemother; 2004 Oct; 54(4):761-6. PubMed ID: 15329364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.